Choose To Lose — Eagle, Idaho

Choose To Lose is a clinical research site located in Eagle, Idaho, United States 83616.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Choose To Lose has participated in 1 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus.

Sponsors: Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Choose To Lose?

Choose To Lose has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Choose To Lose conducted?

Choose To Lose has 1 clinical trials on record. Their work covers Type 2 Diabetes Mellitus.

Is Choose To Lose accredited by Crixeo Health?

Choose To Lose has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Choose To Lose?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.